Filters

Anti-Macrophage Derived Chemokine Antibody

Anti-Macrophage Derived Chemokine Antibody size: 100 μg 514

Supplier ABBEX
Price 514
Size 100 μg
CategoryPrimary Antibodies
Antibody's targetMacrophage Derived Chemokine
ImmunogenSee techfile
ClonalityPolyclonal
The antibody was raised inRabbit
Reactivity Mouse, Rat, Human
PurificationAffinity purified
ApplicationsWB (for other see techfile or inquire)
Stock availabilityShipped within 5-12 working days
Storage conditions Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C
WarningsThis product is for research use only
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by abbex they should be stored frozen at - 24°
Description chemokine receptors, ligands , motif chemokines and cytokines are supplied by abbex in 1, Chemokines
Gene targetMacrophage Derived Chemokine
Short nameAnti-Macrophage Derived Chemokine Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameantibody to-Macrophage Derived Chemokine (Antibody to)
Alternative techniqueantibodies
Identity 6025
Gene CXCL8
Long gene name C-X-C motif chemokine ligand 8
Synonyms gene IL8
Synonyms gene name interleukin 8 chemokine (C-X-C motif) ligand 8
Synonyms SCYB8 LUCT LECT MDNCF TSG-1 IL-8 NAP-1 3-10C MONAP AMCF-I LYNAP NAF b-ENAP GCP-1 K60 GCP1 NAP1
Synonyms name neutrophil-activating peptide 1 granulocyte chemotactic protein 1 monocyte-derived neutrophil chemotactic factor lung giant cell carcinoma-derived chemotactic protein tumor necrosis factor-induced gene 1 monocyte-derived neutrophil-activating peptide lymphocyte derived neutrophil activating peptide beta endothelial cell-derived neutrophil activating peptide alveolar macrophage chemotactic factor I
Locus 4q13, 3
Discovery year 1989-06-30
GenBank acession Y00787
Entrez gene record 3576
Pubmed identfication 1427896 11178128
RefSeq identity NM_000584
Classification Endogenous ligands Chemokine ligands Interleukins
Havana BLAST/BLAT OTTHUMG00000151316

Subscribe to our Newsletter